Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

32.80
-0.2395-0.72%
Post-market: 33.040.2395+0.73%16:10 EDT
Volume:171
Turnover:6K
Market Cap:13.12M
PE:- -
High:32.80
Open:33.04
Low:32.80
Close:33.04
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:0.06
T/O Rate:0.04%
Dividend:0.08
Dividend Rate:0.25%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

BCAL Diagnostics pushes for board shake‑up at Genetic Signatures after lifting stake

TIPRANKS
·
Sep 03

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

GlobeNewswire
·
Sep 03

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 03

Edwards Lifesciences to Present at Deutsche Bank Healthcare Summit

Reuters
·
Sep 03

Johnson & Johnson to Present at Deutsche Bank 2026 Healthcare Summit

Reuters
·
Sep 03

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Reuters
·
Sep 03

Sector Update: Healthcare

MT Newswires Live
·
Sep 03

Johnson & Johnson's Drug Pipeline Supports Growth Outlook, UBS Securities Says

MT Newswires Live
·
Sep 02

LIVE Markets-Wall Street Starts Slow, Dow Leads

Reuters
·
Sep 02

Johnson & Johnson Stock (JNJ) Opened Up by 3.15% on Sep 2: Key Drivers Unveiled

TradingKey
·
Sep 02

Johnson & Johnson, Boeing Share Gains Contribute to Dow's 250-Point Climb

Dow Jones
·
Sep 02

OCUMENSION-B Completes Patient Enrollment in Phase III Trial of Dry Eye Treatment

Stock News
·
Sep 02

Novartis Signs Deal Worth up to $3.2 Billion for Alteogen's Drug Delivery Technology

Reuters
·
Sep 02

Johnson & Johnson assumed with a Buy at UBS

TIPRANKS
·
Sep 02

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.
·
Sep 02

Johnson & Johnson : UBS Raises Target Price to $320 from $280

THOMSON REUTERS
·
Sep 02

Merck CFO Litchfield, R&D Chief Li to Speak at Wells Fargo Healthcare Conference

Reuters
·
Sep 02

Guangdong Zhongsheng Pharmaceutical (002317.SZ) Secures NMPA Acceptance for Expanded Indication Trial of Onradivir Tablets

Stock News
·
Sep 02

CareDx initiated with a Buy at Canaccord

TIPRANKS
·
Sep 02